Biocon And Zentiva Hail Milestone Liraglutide Approval In UK

Partners Plan For ‘Expeditious’ Launch After Claiming Leading Position On GLP-1

 
• By Dave Wallace

Biocon and Zentiva have celebrated the “first generic liraglutide approved in a major regulated/ICH market” after an endorsement from the UK’s MHRA.

UK flag on thumb up gesture like icon
Biocon and Zentiva received approval for liraglutide in the UK

More from Products

More from Generics Bulletin